Cargando…

Newly developed 3D in vitro models to study tumor–immune interaction

Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer treatment and revitalized the field of tumor immunology research. 3D in vitro models are emerging as powerful tools considering their feature to maintain tumor cells in a near-native state and have been widely appli...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Peiyuan, Zhou, Shujuan, Lv, Tao, Xia, Fan, Shen, Lijun, Wan, Juefeng, Wang, Yaqi, Zhang, Hui, Cai, Sanjun, Peng, Junjie, Hua, Guoqiang, Zhang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074642/
https://www.ncbi.nlm.nih.gov/pubmed/37016422
http://dx.doi.org/10.1186/s13046-023-02653-w
_version_ 1785019780204331008
author Mu, Peiyuan
Zhou, Shujuan
Lv, Tao
Xia, Fan
Shen, Lijun
Wan, Juefeng
Wang, Yaqi
Zhang, Hui
Cai, Sanjun
Peng, Junjie
Hua, Guoqiang
Zhang, Zhen
author_facet Mu, Peiyuan
Zhou, Shujuan
Lv, Tao
Xia, Fan
Shen, Lijun
Wan, Juefeng
Wang, Yaqi
Zhang, Hui
Cai, Sanjun
Peng, Junjie
Hua, Guoqiang
Zhang, Zhen
author_sort Mu, Peiyuan
collection PubMed
description Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer treatment and revitalized the field of tumor immunology research. 3D in vitro models are emerging as powerful tools considering their feature to maintain tumor cells in a near-native state and have been widely applied in oncology research. The novel 3D culture methods including the co-culture of organoids and immune cells, ALI culture, 3D-microfluidic culture and 3D-bioprinting offer new approaches for tumor immunology study and can be applied in many fields such as personalized treatment, immunotherapy optimizing and adoptive cell therapy. In this review, we introduce commonly used 3D in vitro models and summarize their applications in different aspects of tumor immunology research. We also provide a preliminary analysis of the current shortcomings of these models and the outlook of future development.
format Online
Article
Text
id pubmed-10074642
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100746422023-04-06 Newly developed 3D in vitro models to study tumor–immune interaction Mu, Peiyuan Zhou, Shujuan Lv, Tao Xia, Fan Shen, Lijun Wan, Juefeng Wang, Yaqi Zhang, Hui Cai, Sanjun Peng, Junjie Hua, Guoqiang Zhang, Zhen J Exp Clin Cancer Res Review Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer treatment and revitalized the field of tumor immunology research. 3D in vitro models are emerging as powerful tools considering their feature to maintain tumor cells in a near-native state and have been widely applied in oncology research. The novel 3D culture methods including the co-culture of organoids and immune cells, ALI culture, 3D-microfluidic culture and 3D-bioprinting offer new approaches for tumor immunology study and can be applied in many fields such as personalized treatment, immunotherapy optimizing and adoptive cell therapy. In this review, we introduce commonly used 3D in vitro models and summarize their applications in different aspects of tumor immunology research. We also provide a preliminary analysis of the current shortcomings of these models and the outlook of future development. BioMed Central 2023-04-04 /pmc/articles/PMC10074642/ /pubmed/37016422 http://dx.doi.org/10.1186/s13046-023-02653-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Mu, Peiyuan
Zhou, Shujuan
Lv, Tao
Xia, Fan
Shen, Lijun
Wan, Juefeng
Wang, Yaqi
Zhang, Hui
Cai, Sanjun
Peng, Junjie
Hua, Guoqiang
Zhang, Zhen
Newly developed 3D in vitro models to study tumor–immune interaction
title Newly developed 3D in vitro models to study tumor–immune interaction
title_full Newly developed 3D in vitro models to study tumor–immune interaction
title_fullStr Newly developed 3D in vitro models to study tumor–immune interaction
title_full_unstemmed Newly developed 3D in vitro models to study tumor–immune interaction
title_short Newly developed 3D in vitro models to study tumor–immune interaction
title_sort newly developed 3d in vitro models to study tumor–immune interaction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074642/
https://www.ncbi.nlm.nih.gov/pubmed/37016422
http://dx.doi.org/10.1186/s13046-023-02653-w
work_keys_str_mv AT mupeiyuan newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT zhoushujuan newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT lvtao newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT xiafan newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT shenlijun newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT wanjuefeng newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT wangyaqi newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT zhanghui newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT caisanjun newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT pengjunjie newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT huaguoqiang newlydeveloped3dinvitromodelstostudytumorimmuneinteraction
AT zhangzhen newlydeveloped3dinvitromodelstostudytumorimmuneinteraction